Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared on LinkedIn:
“ASCO25 starts with ctDNA and colorectal cancer.
New Advancement
Whole Exome vs Whole Genome-based tumor-informed liquid biopsies.
My experience: WGS is picking more ‘WES-false-negatives’.
Higher sensitivity leads to more MRD utility questions – early stage, ultra-low shed…”
More posts featuring Pashtoon Kasi on OncoDaily.